ND-2158 | Interleukin Related interleukin-related.com

Product Name :
ND-2158

Search keywords :
ND-2158

drugId :
null

Target Vo:
Interleukin-1 receptor-associated kinase 4

Target Vo Short Name :
IRAK4

Moa_Name:
Interleukin-1 receptor-associated kinase 4 inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Nimbus Therapeutics LLC

Active Company_Name :
Nimbus Therapeutics LLC

Active Indication_Name:
Arthritis

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Preclinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Phospho-Creb (S133) Rabbit mAb Biological Activity
Hsp27 (YP6091) Mouse mAb Purity & Documentation
Phospho-BTK(Y223) Antibody: Phospho-BTK(Y223) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 76 kDa, targeting to Phospho-BTK(Y223). It can be used for WB, IHC-P, IHC-F, ICC, IF assays with tag free, in the background of Human.

Author: Interleukin Related

Related Posts